The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Interest of pretreatment quantification of anti-cetuximab IgE to prevent severe hypersensitivity reaction to cetuximab.
Benoit Dupont
No relevant relationships to disclose
Delphine Mariotte
No relevant relationships to disclose
Audrey Emmanuelle Dugue
No relevant relationships to disclose
Benedicte Clarisse
No relevant relationships to disclose
Jean-Michel Grellard
No relevant relationships to disclose
Emmanuel Babin
No relevant relationships to disclose
Bruno Chauffert
No relevant relationships to disclose
Stephanie Dakpe
No relevant relationships to disclose
Cristian Moldovan
No relevant relationships to disclose
Jean-Marie Reimund
No relevant relationships to disclose
Frédéric Di Fiore
No relevant relationships to disclose
Sylvie Zanetta
No relevant relationships to disclose
Marian Degardin
No relevant relationships to disclose
Pascal Do
No relevant relationships to disclose
Annie Peytier
No relevant relationships to disclose
Marie-Pierre Galais
No relevant relationships to disclose
Carmen Florescu
No relevant relationships to disclose
Roland Schott
No relevant relationships to disclose
Brigitte Le Mauff
No relevant relationships to disclose
Radj Gervais
No relevant relationships to disclose